Organon & Co | Umsatzkosten



Cost Of Sales Veränderung Datum
Adcock Ingram Holdings ZAR 3.18B 115.21M 2024-12
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Celltrion KRW 399.04B 297.8B 2025-03
Cspc Pharmaceutical CNY 2.07B 71.26M 2024-09
Divis Laboratories Ltd 9.22B 470M 2024-12
Gilead Sciences USD 1.54B 41M 2025-03
Glaxosmithkline GBP 2.52B 199M 2024-12
Kangmei Pharma CNY 1.21B 124.7M 2024-09
Knight Therapeutics CAD 47.25M 990K 2024-09
Laboratorios Farma EUR 152.05M 84.2M 2024-12
Malin Corporation EUR 15.4M 0 2020-12
Medical Developments International AUD 2.35M 1.73M 2024-06
Merck USD 2.76B 944M 2025-03
Novartis USD 3.31B 73M 2024-12
Organigram Holdings CAD 41.68M 69.31M 2024-12
Organon & Co USD 672M 24M 2025-03
Pharma Mar EUR 3.4M 2.09M 2025-03
Qiagen NV USD 187.91M 16.67M 2024-12
Sartorius EUR 452M 60.2M 2025-03
Sino Biopharmaceutical CNY 2.49B 1.07B 2024-12
Tilray USD 149.73M 9.39M 2024-11



Organon & Co Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.